Quick Takeaways
- Ronit Simantov has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,016,639.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Ronit Simantov
- Location
- New Haven, CT
- Summary
- The estimated net worth of Ronit Simantov is at least $1,016,639 dollars as of 28 Jan 2026. Ronit Simantov is the CMO & CHIEF SCIENTIFIC OFFICER of Gamida Cell Ltd. and owns shares of Gamida Cell Ltd. stock worth about $1.02M.
- Signature
- /s/ Nicholas Maestas, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ronit Simantov and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Gamida Cell Ltd. ($1,016,639).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ronit Simantov
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GMDA | Gamida Cell Ltd. | Cmo & Chief Scientific Officer | $1,016,639 | 31 Jan 2024 | ||
| CLVS | Clovis Oncology, Inc. | Director | 12 Jul 2021 | |||
| TPST | Tempest Therapeutics, Inc. | Director | 27 Jan 2026 |
Insider Transactions Reported by Ronit Simantov:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.